SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "hsv:(MEDICIN OCH HÄLSOVETENSKAP) hsv:(Medicinska grundvetenskaper) ;srt2:(1995-2009)"

Sökning: hsv:(MEDICIN OCH HÄLSOVETENSKAP) hsv:(Medicinska grundvetenskaper) > (1995-2009)

Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
51.
  •  
52.
  • Mamontov, Eugen, 1955-, et al. (författare)
  • The minimal, phase-transition model for the cell-number maintenance by the hyperplasia-extended homeorhesis
  • 2006
  • Ingår i: Acta Biotheoretica. - 0001-5342. ; 54:2, s. 61-101
  • Tidskriftsartikel (refereegranskat)abstract
    • Oncogenic hyperplasia is the first and inevitable stage of formation of a (solid) tumor. This stage is also the core of many other proliferative diseases. The present work proposes the first minimal model that combines homeorhesis with oncogenic hyperplasia where the latter is regarded as a genotoxically activated homeorhetic dysfunction. This dysfunction is specified as the transitions of the fluid of cells from a fluid, homeorhetic state to a solid, hyperplastic-tumor state, and back. The key part of the model is a nonlinear reaction-diffusion equation (RDE) where the biochemical-reaction rate is generalized to the one in the well-known Schlögl physical theory of the non-equilibrium phase transitions. A rigorous analysis of the stability and qualitative aspects of the model, where possible, are presented in detail. This is related to the spatially homogeneous case, i.e. when the above RDE is reduced to a nonlinear ordinary differential equation. The mentioned genotoxic activation is treated as a prevention of the quiescent G0-stage of the cell cycle implemented with the threshold mechanism that employs the critical concentration of the cellular fluid and the nonquiescent-cell-duplication time. The continuous tumor morphogeny is described by a time-space-dependent cellular-fluid concentration. There are no sharp boundaries (i.e. no concentration jumps exist) between the domains of the homeorhesis- and tumor-cell populations. No presumption on the shape of a tumor is used. To estimate a tumor in specific quantities, the model provides the time-dependent tumor locus, volume, and boundary that also points out the tumor shape and size. The above features are indispensable in the quantitative development of antiproliferative drugs or therapies and strategies to prevent oncogenic hyperplasia in cancer and other proliferative diseases. The work proposes an analytical-numerical method for solving the aforementioned RDE. A few topics for future research are suggested.
  •  
53.
  • Matsui, S, et al. (författare)
  • Active immunization of combined beta1-adrenoceptor and M2-muscarinic receptor peptides induces cardiac hypertrophy in rabbits.
  • 1999
  • Ingår i: Journal of cardiac failure. - 1071-9164. ; 5:3, s. 246-54
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: The high prevalence of patients with dilated cardiomyopathy (DCM) with anti-beta1-adrenoceptor and/or anti-M2-muscarinic receptor autoantibodies in their sera has been observed. However, the pathophysiological role of these autoantibodies in the development of cardiomyopathy is unknown. We previously reported an experimental model of early-stage DCM-like cardiomyopathy induced by immunizing rabbits for 1 year with synthetic peptides corresponding to the sequence of the second extracellular loop of either beta1-adrenoceptor or M2-muscarinic receptor. Because approximately half the sera of patients with DCM that recognize one of the two receptor sequences also recognize the second sequence, a model was created in rabbits simultaneously immunized with the synthetic peptides corresponding to the second extracellular loop of the beta1-adrenoceptor and M2-muscarinic receptor. METHODS AND RESULTS: All rabbits (n = 8) immunized with both peptides had a high titer of both anti-beta1-adrenoceptor and anti-M2-muscarinic receptor autoantibodies in their sera, whereas none of the sera from control rabbits injected with saline (n = 9) was positive. No significant cross-reaction with peptides other than those used for immunization was found. The weight of the hearts of immunized rabbits increased significantly. The hearts of immunized rabbits showed marked concentric left ventricular hypertrophy with mild inflammatory cell infiltration. In these rabbits, mild or moderate interstitial fibrosis was also observed. In electron micrographs, immunized rabbits showed focal myofibrillar lysis, loss of myofilament, and a marked increase in the number of mitochondria and deposition of dense granules in both sarcoplasm and myofibrils. Conversely, one of the control rabbits showed scant mononuclear cell infiltration. However, in this control rabbit, no significant alteration was found by electron microscopy. CONCLUSION: Our results showed the coexistence of both anti-beta1-adrenoceptor and anti-M2-muscarinic receptor autoantibodies in the sera has pathophysiological importance, shown by their ability to induce cardiac hypertrophy in rabbits.
  •  
54.
  • Matsui, Shinobu, et al. (författare)
  • Amiodarone minimizes experimental autoimmune myocarditis in rats.
  • 2003
  • Ingår i: European journal of pharmacology. - 0014-2999. ; 469:1-3, s. 165-73
  • Tidskriftsartikel (refereegranskat)abstract
    • Amiodarone, a promising drug for the treatment of tachyarrythmias, was recently found to have immunomodulatory effects in vitro. We hypothesized that amiodarone would affect the immune system in vivo and examined the effect of amiodarone on myocarditis in rats. We induced experimental autoimmune myocarditis in rats by cardiac myosin immunization and treated the animals with an intraperitoneal injection of amiodarone at 25 mg/kg/every other day, 10 times after the induction of experimental autoimmune myocarditis. In the treated group, both microscopic and macroscopic examinations showed reduced heart weights, a mild and localized infiltration of inflammatory cells and fibrosis in the myocardium, and a mild congestion in the liver and lungs as compared with the control group. The phenotypic distribution of lymphocytes in peripheral blood showed a significant decrease in the CD4/CD8a ratio in the treated group, but not in the control group. The proportion of mast cells involved in inflammatory cell infiltration was lower in the treated group than the control group. In vitro, amiodarone inhibited the proliferation of mast cells by arresting them in the G2 phase of the cell cycle. These results indicated that amiodarone minimized the progression of experimental autoimmune myocarditis, suggesting a potential therapeutic role for amiodarone treatment in patients suffering from myocarditis, especially myocarditis complicated by cardiac arrhythmias. One possible mechanism by which amiodarone minimizes the progression of experimental autoimmune myocarditis may be to affect the immune system via the immunomodulatory effects on T cell and mast cell functions.
  •  
55.
  • Matsui, S, et al. (författare)
  • Beneficial effect of muscarinic-2 antagonist on dilated cardiomyopathy induced by autoimmune mechanism against muscarinic-2 receptor.
  • 2001
  • Ingår i: Journal of cardiovascular pharmacology. - 0160-2446. ; 38 Suppl 1, s. S43-9
  • Tidskriftsartikel (refereegranskat)abstract
    • We have previously shown that a peptide corresponding to the sequence of the second extracellular loop of the human muscarinic-2 (M2) receptor (M2-peptide) was able to induce an autoimmune cardiomyopathy in rabbits. In this study, we investigated the effect of M2-antagonist (otenzepad) on M2-peptide-induced cardiomyopathy in rabbits. New Zealand White rabbits were divided into four groups: 1) control group, saline injection; 2) M2-peptide group, M2-peptide injection; 3) M2-antagonist group, otenzepad (30 mg/day) orally and saline injection; and (4) M2-antagonist + M2-peptide group, otenzepad (30 mg/day) orally and M2-peptide injection. The study duration was 1 year. Saline or peptide was injected once a month. All rabbits in both the M2-peptide group and the M2-antagonist + M2-peptide group had high titers of anti-M2-autoantibodies in their sera. Rabbits in the M2-peptide group showed an increase in heart weight, wall thinning and dilatation of the right ventricle. On the contrary, rabbits in the M2-antagonist + M2-peptide group had normal heart weight and shape. All rabbits in the M2-peptide group showed multifocal degeneration and necrosis of myocardial cells with moderate infiltration of inflammatory cells, while four rabbits in the M2-antagonist + M2-peptide group showed slight infiltration of inflammatory cells with normal myocardial cells and interstitium, and another three showed no histological changes in the hearts. In conclusion, M2-antagonist protects the myocardium from injury induced by autoimmune mechanism against M2-muscarinic receptor.
  •  
56.
  • Matsui, S, et al. (författare)
  • Myocardial injury due to G-protein coupled receptor-autoimmunity.
  • 1998
  • Ingår i: Japanese heart journal. - 0021-4868. ; 39:3, s. 261-74
  • Tidskriftsartikel (refereegranskat)abstract
    • One of the main mechanisms for dilated cardiomyopathy is likely to be autoimmune mediated myocardial damage. So far, a variety of autoantibodies have been detected against a number of putative autoantigens in the sera of patients with dilated cardiomyopathy. A growing body of studies have confirmed that autoantibodies against the second extracellular loop of beta 1-adrenoceptors and M2-muscarinic receptor are present in 30-40% of patients with dilated cardiomyopathy. These anti-beta 1-adrenoceptor and anti-M2-muscarinic receptor antibodies can not only decrease the binding sites of antagonist but also recognize the target receptors. Moreover, these two autoantibodies possess an 'agonist-like' stimulatory effect on the target receptors. In order to elucidate whether the autoantibodies against these autoimmune epitopes play an important role in the pathogenesis of dilated cardiomyopathy, we immunized rabbits over a period of one year with synthetic peptides corresponding to the second extracellular loop of the beta 1-adrenoceptor and the M2-muscarinic receptor. These peptides induced morphological changes in the heart similar to those found in dilated cardiomyopathy. These clinical and experimental findings suggest that these receptor autoantigens are of pathogenic importance in the development of dilated cardiomyopathy in vivo.
  •  
57.
  • Matsui, S, et al. (författare)
  • Peptides derived from cardiovascular G-protein-coupled receptors induce morphological cardiomyopathic changes in immunized rabbits.
  • 1997
  • Ingår i: Journal of molecular and cellular cardiology. - 0022-2828. ; 29:2, s. 641-55
  • Tidskriftsartikel (refereegranskat)abstract
    • An experimental model of early-stage cardiomyopathy was created by immunizing rabbits for 1 year with synthetic peptides corresponding to the sequence of the second extracellular loop of either beta-adrenoceptors or M2-muscarinic receptors. Thirty male rabbits were used and divided into three groups: a control group (n = 10), a group immunized with the peptide corresponding to the beta-adrenoceptor (beta 1 group) (n = 10) and a group immunized with the peptide corresponding to the M2-muscarinic receptor (M2 group) (n = 10). If the sera from both groups of immunized rabbits high-titres of anti-peptide antibodies were found throughout the study period but not in the sera from control rabbits or in the preimmune sera of immunized rabbits. No significant cross-reaction with peptides other than those used for immunization was found. The myocardial receptor density of both immunized groups displayed a strong trend toward receptor up-regulation. This was significant in the beta 1 group but not in the M2 group. Both groups of immunized rabbits displayed significantly enlarged ventricles and thinner walls, as compared with the control group. However, in contrast to the beta 1 group, which showed enlarged cavities in both left and right ventricles, the M2 group was mainly affected in the right ventricles. Moreover, morphological examinations of the hearts of rabbits from both immunized groups demonstrated focal myofibrillar lysis, loss of myofilament, mitochondrial swelling and condensation, sarcoplasmic vacuolation, deposition of dense granules in the sarcoplasm and the myofibrils. One of the sex control rabbit hearts which were examined showed mild degenerative changes in the myocardium and scant mononuclear cell infiltration. However, when all the control rabbit hearts were examined by electron microscopy, no significant alterations were found. These results suggest that immunization by peptides, corresponding to the target sequences for anti-receptor autoantibodies in idiopathic dilated cardiomyopathy, induces morphological changes in the heart similar to those found in the human disease.
  •  
58.
  • Matsui, S, et al. (författare)
  • Protective effect of bisoprolol on beta-1 adrenoceptor peptide-induced autoimmune myocardial damage in rabbits.
  • 2000
  • Ingår i: Herz. - 0340-9937. ; 25:3, s. 267-70
  • Tidskriftsartikel (refereegranskat)abstract
    • Idiopathic dilated cardiomyopathy is a severe disease of unknown etiology. Accumulating evidence suggests that agonist-like autoantibodies against the beta 1 adrenoceptor in the circulation of dilated cardiomyopathy may play an important role. The aim of this study was to evaluate the effects of the selective beta 1-adrenoceptor blocker, bisoprolol, on beta 1-adrenoceptor peptide induced autoimmune myocardial damage. In the animal model of autoimmune cardiomyopathy induced by active immunization of rabbits with beta 1-adrenoceptor peptide, bisoprolol was given at a dose of 3 mg/day throughout the study period. Our results showed high titer of anti-beta 1-adrenoceptor antibody in the immunized group throughout the study but not in the group receiving only bisoprolol. Cross-reactivity to beta 2 adrenoceptors was observed in some of the immunized rabbits, but disappeared almost entirely after 6 months. As compared to the beta 1-adrenoceptor peptide immunized group without bisoprolol treatment, bisoprolol treated beta 1-receptor peptide immunized group showed increase in the wall thickness and decreases in cavity dimension in anatomical measurements and only mild alterations in macro- and microscopic examinations. Thus, our study clearly demonstrated a beneficial effect of bisoprolol in rabbits who have developed autoimmune myocardial damage.
  •  
59.
  • Matsui, Shinobu, et al. (författare)
  • Specific removal of beta1-adrenoceptor autoantibodies by immunoabsorption in rabbits with autoimmune cardiomyopathy improved cardiac structure and function.
  • 2006
  • Ingår i: Journal of molecular and cellular cardiology. - 0022-2828. ; 41:1, s. 78-85
  • Tidskriftsartikel (refereegranskat)abstract
    • Growing evidence suggests that the beta1-adrenoceptor-directed autoimmune mechanism may play an important role in the pathogenesis of idiopathic dilated cardiomyopathy. The aim of this study is to further study the effect of specific immunoabsorption of anti-beta1-adrenoceptor autoantibodies on cardiac structure and function in autoimmune cardiomyopathy in rabbits. Twenty-four male rabbits were divided into 2 groups: (1) one immunized with beta1-adrenoceptor peptide (beta1 group, n=16), and (2) the other receiving saline injection as a control (control group, n=8). Immunization was performed once a month for 8 months. A high concentration of anti-beta1-adrenoceptor autoantibodies was exhibited throughout the immunization period. Rabbits in the beta1 group showed increased left ventricular end-diastolic diameter (LVDd), decreased left ventricular ejection fraction (LVEF) and increased LV mass/body weight ratio after the 8th month. Immunoabsorption with beta1-adrenoceptor peptide column was able to remove up to 35% of anti-beta1-adrenoceptor autoantibodies in 2 h, resulting in decreased LVDd and increased LVEF 3 months after. Specific removal of anti-beta1-adrenoceptor autoantibodies improved cardiac structure and function in experimental autoimmune cardiomyopathy. These results suggest that anti-beta1-adrenoceptor autoantibodies are of pathogenic importance in the induction of cardiomyopathy, and that specific immunoabsorption as an emerging therapy may be considered when anti-beta1-adrenoceptor autoantibodies are pathophysiologically involved.
  •  
60.
  • Matsui, Shinobu, et al. (författare)
  • Transfer of rabbit autoimmune cardiomyopathy into severe combined immunodeficiency mice.
  • 2003
  • Ingår i: Journal of cardiovascular pharmacology. - 0160-2446. ; 42 Suppl 1, s. S99-103
  • Tidskriftsartikel (refereegranskat)abstract
    • Growing evidence suggests that the autoimmune mechanism plays an important role in the pathogenesis of dilated cardiomyopathy. The purpose of this study was to evaluate the effect on the cardiac structure and function by the transfer of immunoglobulin G (IgG) and/or lymphocytes from rabbits immunized with a synthetic peptide corresponding to the sequence of the second extracellular loop of beta1-adrenoceptor (beta peptide) into severe combined immunodeficiency (SCID) mice. CB-17 SCID mice were injected intraperitoneally with 2 mg of IgG and/or 1 x 10(7) peripheral blood lymphocytes (PBL) from either rabbits immunized with both beta1 peptide and adjuvant (beta group), and adjuvant or rabbits with adjuvant only (N group). Thirty-five SCID mice were divided into seven groups: (1) N-IgG group; (2) N-PBL group; (3) N-IgG+PBL group; (4) beta-IgG group; (5) beta-PBL group; (6) beta-IgG+PBL group; and (7) control group. Morphological, serological and endocrinological studies were performed 70 days after the transfer. Results showed that heart weight and heart weight/body weight ratio in the beta-IgG+PBL group tended to be increased as compared with those in other groups. All mice in the beta-IgG group, two in the beta-PBL group and four in the beta-IgG+PBL group showed high titer of rabbit anti-beta1-adrenoceptor antibodies. Brain natriuretic peptide in the beta-IgG+PBL group showed a significant increase as compared with those in the control group and N-IgG+PBL. Pathohistologically, focal infiltration of inflammatory cells in the myocardium was observed in one mouse of the beta-IgG+PBL group. Rabbit CD3-positive T-lymphocytes in the myocardium were observed in two mice of the beta group. In conclusion, transfer of IgG and PBL from rabbits immunized with beta1 peptide was able to induce the early stages of myocardial damage in SCID mice. These data provide direct evidence that the autoimmune mechanism is important in the pathogenesis of dilated cardiomyopathy.
  •  
Skapa referenser, mejla, bekava och länka
Åtkomst
fritt online (2057)
Typ av publikation
tidskriftsartikel (9818)
doktorsavhandling (1476)
konferensbidrag (780)
forskningsöversikt (515)
bokkapitel (265)
annan publikation (31)
visa fler...
licentiatavhandling (29)
bok (26)
rapport (24)
recension (18)
samlingsverk (redaktörskap) (15)
patent (12)
proceedings (redaktörskap) (1)
visa färre...
Typ av innehåll
refereegranskat (10788)
övrigt vetenskapligt (2856)
populärvet., debatt m.m. (53)
Författare/redaktör
Borrebaeck, Carl, (158)
Holmdahl, Rikard, (122)
Vihinen, Mauno, (119)
Brundin, Patrik, (98)
Mertens, Fredrik, (93)
Blom, Anna, (90)
visa fler...
Dahlbäck, Björn, (89)
Wadström, Torkel, (84)
Wingren, Christer, (80)
Fu, Michael, 1963-, (79)
Lammi, Mikko, 1961-, (76)
Ohlin, Mats, (74)
Grubb, Anders, (68)
Dillner, Joakim, (68)
Abrahamson, Magnus, (66)
Lindvall, Olle, (66)
Jankowska, Elzbieta, (64)
Falsen, Enevold, 193 ... (63)
Eriksson, Elias, 195 ... (62)
Johansson, Bertil, (61)
Svanborg, Catharina, (60)
Björklund, Anders, (59)
Edvinsson, Lars, (58)
Bohlin, Lars, (58)
Blennow, Kaj, 1958-, (56)
Wennergren, Göran, 1 ... (55)
Backhaus, Thomas, 19 ... (54)
Ljungh, Åsa, (53)
Mitelman, Felix, (53)
Riesbeck, Kristian, (52)
Gisselsson Nord, Dav ... (52)
Kokaia, Zaal, (52)
James, Peter, (52)
Höglund, Mattias, (51)
Funa, Keiko, 1949-, (51)
Eiken, Ola, (50)
Gisslén, Magnus, 196 ... (48)
Larsson, Lennart, (48)
Sundler, Frank, (47)
Nylander, Ingrid, (46)
Karlsson, Mats O., (45)
Svennerholm, Ann-Mar ... (45)
Rönnstrand, Lars, (45)
Fenyö, Eva Maria, (44)
Holmgren, Jan, 1944- ... (44)
Birnir, Bryndis, (44)
Leffler, Hakon, (43)
Mörgelin, Matthias, (43)
Dahlgren, Claes, 194 ... (43)
Petersén, Åsa, (43)
visa färre...
Lärosäte
Lunds universitet (5627)
Göteborgs universitet (3220)
Uppsala universitet (2017)
Umeå universitet (833)
Karolinska Institutet (652)
Kungliga Tekniska Högskolan (295)
visa fler...
Chalmers tekniska högskola (295)
Örebro universitet (245)
Stockholms universitet (220)
Linköpings universitet (194)
swepub_uni:mau_t (90)
Linnéuniversitetet (77)
Gymnastik- och idrottshögskolan (71)
Mittuniversitetet (55)
Högskolan i Skövde (29)
Högskolan Kristianstad (25)
Högskolan i Halmstad (19)
Sveriges Lantbruksuniversitet (17)
Högskolan i Jönköping (16)
Högskolan i Borås (16)
Högskolan Dalarna (13)
Mälardalens högskola (8)
Karlstads universitet (8)
Högskolan Väst (7)
Södertörns högskola (7)
Högskolan i Gävle (7)
Röda Korsets Högskola (2)
Försvarshögskolan (1)
Ersta Sköndal Bräcke högskola (1)
VTI - Statens väg- och transportforskningsinstitut (1)
visa färre...
Språk
Engelska (12689)
Svenska (272)
Spanska (14)
Finska (8)
Kinesiska (5)
Tyska (4)
visa fler...
Danska (3)
Ryska (3)
Norska (2)
Odefinierat språk (2)
Ungerska (2)
Franska (1)
Polska (1)
Isländska (1)
Rumänska (1)
Turkiska (1)
Annat språk (1)
visa färre...
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (13010)
Naturvetenskap (720)
Samhällsvetenskap (190)
Teknik (136)
Humaniora (55)
Lantbruksvetenskap (33)

År

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy